243 related articles for article (PubMed ID: 1972370)
1. [Effects of IT-066, a new histamine H2-receptor antagonist, on gastric acid secretion and experimental gastric ulcers in rats and dogs].
Okabe S; Nishida T; Igata H; Takagi K
Nihon Yakurigaku Zasshi; 1990 May; 95(5):247-56. PubMed ID: 1972370
[TBL] [Abstract][Full Text] [Related]
2. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
[TBL] [Abstract][Full Text] [Related]
3. Effects of a new histamine H2-receptor antagonist, Z-300, on gastric secretion and gastro-duodenal lesions in rats: comparison with roxatidine.
Okabe S; Takagi K; Igata H; Kato S; Shimosako K; Yamaji Y; Seiki M
Jpn J Pharmacol; 1992 Jul; 59(3):275-89. PubMed ID: 1359178
[TBL] [Abstract][Full Text] [Related]
4. [Effects of IGN-2098, a new histamine H2-receptor antagonist, on gastric secretion and gastric and duodenal lesions induced in rats. Comparison with roxatidine].
Okabe S; Narita M; Nakaji S; Takinami Y; Kawano O; Misaki N
Nihon Yakurigaku Zasshi; 1992 Mar; 99(3):167-80. PubMed ID: 1354631
[TBL] [Abstract][Full Text] [Related]
5. Antisecretory and ulcer healing effects of S-0509, a novel CCK-B/gastrin receptor antagonist, in rats.
Amagase K; Ikeda K; Okabe S
Dig Dis Sci; 1999 May; 44(5):879-88. PubMed ID: 10235591
[TBL] [Abstract][Full Text] [Related]
6. Antisecretory and antilesional effect of a new histamine H2-receptor antagonist, IT-066, in rats.
Isobe Y; Nagai H; Muramatsu M; Aihara H; Otomo S
J Pharmacol Exp Ther; 1990 Dec; 255(3):1078-82. PubMed ID: 1979811
[TBL] [Abstract][Full Text] [Related]
7. Effects of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist, on gastric acid secretion and ulcer formation.
Tarutani M; Sakuma H; Shiratsuchi K; Mieda M
Arzneimittelforschung; 1985; 35(5):844-8. PubMed ID: 2862875
[TBL] [Abstract][Full Text] [Related]
8. [Effects of FRG-8813, a new-type histamine H2-receptor antagonist, on the healing of gastric and duodenal ulcer in rats and spontaneously ulcerative mice].
Yamaura T; Shibata M; Chida Y; Inaba N; Onodera S; Ohnishi H
Nihon Yakurigaku Zasshi; 1992 Jun; 99(6):411-20. PubMed ID: 1356898
[TBL] [Abstract][Full Text] [Related]
9. Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
Sekiguchi H; Hamada K; Aijima H; Taga F; Uchida H; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):139-43. PubMed ID: 8096134
[TBL] [Abstract][Full Text] [Related]
10. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
Shibata M; Yamaura T; Inaba N; Onodera S; Chida Y; Ohnishi H
Eur J Pharmacol; 1993 Apr; 235(2-3):245-53. PubMed ID: 8099553
[TBL] [Abstract][Full Text] [Related]
11. Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
Nagaya H; Inatomi N; Satoh H
Jpn J Pharmacol; 1991 Apr; 55(4):425-36. PubMed ID: 1886288
[TBL] [Abstract][Full Text] [Related]
12. [Effects of nizatidine, a new histamine H2-receptor antagonist, on gastric acid secretion and various gastric and duodenal lesions in rats: comparison with cimetidine].
Okabe S; Takeuchi K; Okada M; Kumadaki Y; Nakata M; Nakata H
Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):133-44. PubMed ID: 2567267
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological and therapeutic properties of lafutidine (stogar and protecadin), a novel histamine H2 receptor antagonist with gastroprotective activity].
Tanaka M; Banba M; Joko A; Moriyama Y
Nihon Yakurigaku Zasshi; 2001 Jun; 117(6):377-86. PubMed ID: 11436515
[TBL] [Abstract][Full Text] [Related]
14. Effect of BMY-25368, a potent and long-acting histamine H2-receptor antagonist, on gastric secretion and aspirin-induced gastric lesions in the dog.
Cavanagh RL; Buyniski JP
Aliment Pharmacol Ther; 1989 Jun; 3(3):299-313. PubMed ID: 2577694
[TBL] [Abstract][Full Text] [Related]
15. [Effect of an H+, K+-ATPase inhibitor, omeprazole (OPZ), on gastric acid secretion and gastric or duodenal lesion. Comparison with an H2-receptor antagonist, famotidine (FMD)].
Haga K; Asano K; Osuga K; Maruyama Y
Nihon Yakurigaku Zasshi; 1988 Jul; 92(1):39-47. PubMed ID: 2906028
[TBL] [Abstract][Full Text] [Related]
16. Effect of NC-1300-O-3 on healing of acetic acid-induced gastric ulcers in rats.
Okabe S; Takagi K; Inoue K
Jpn J Pharmacol; 1993 May; 62(1):25-33. PubMed ID: 8341026
[TBL] [Abstract][Full Text] [Related]
17. Effect of the novel histamine H2-antagonist 5,6-dimethyl-2-[4-[3-(1- piperidinomethyl)phenoxy]-(z)-2-butenylamino]-4(1H)-pyrimidine dihydrochloride on histamine-induced gastric acid secretion in Heidenhain pouch dogs.
Uchida M; Ohba S; Ikarashi Y; Misaki N; Kawano O
Arzneimittelforschung; 1993 Aug; 43(8):873-6. PubMed ID: 8105784
[TBL] [Abstract][Full Text] [Related]
18. Effects of FRG-8701 on gastric acid secretion, gastric mucosal lesions by necrotizing agents and experimental gastric or duodenal ulcer in rats.
Shibata M; Yamaura T; Sekine A; Nishikawa M; Chida Y; Ohnishi H
Jpn J Pharmacol; 1990 Nov; 54(3):277-85. PubMed ID: 1982548
[TBL] [Abstract][Full Text] [Related]
19. [Effect of lafutidine, a novel antiulcer agent, on healing and relapse of acetic acid-induced gastric ulcer in rats].
Onodera S; Tanaka M; Aoyama M; Arai Y; Shibata M; Yamaura T; Ohnishi H
Nihon Yakurigaku Zasshi; 1998 Mar; 111(3):167-75. PubMed ID: 9583080
[TBL] [Abstract][Full Text] [Related]
20. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
